secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-10-16T21:15:16+00:00
Accession:  0001493152-26-047451
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.01, 3.02
LLM model:  deepseek-v4.1-flash:cloud@v2

DataMeds AI licenses REBOOT Health AI platform for $2M stock; says it regained Nasdaq equity compliance
--------------------------------------------------------------------------------

- IP License Agreement dated Oct 13, 2026 with REBOOT Health AI: exclusive US license for GLP-1 weight management B2C use; consideration 666,667 shares valued at $2,000,000.
- If share value is below $2,000,000 after 180 days, DataMeds must issue more shares using 10-day VWAP; also paying REBOOT $50,000 toward a minimum $100,000 reconfiguration.
- Nasdaq: April 13, 2026 deficiency letter cited $(12,447,801) stockholders' equity at FY2025 vs $2,500,000 minimum under Rule 5550(b)(1); company believes it now exceeds $2.5M after transactions.
- Compliance steps: converted ~$1.5M vendor payables to stock (Jul-Oct 2026), issued 636,328 shares for Helomics acquisition, and a Sept 17, 2026 settlement extinguished ~$18.7M debt.
- License runs perpetually until last patent expires, terminable for uncured breach after 30-day notice or missed minimum revenue thresholds; REBOOT retains platform IP and source code.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226047451/0001493152-26-047451-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226047451/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-047451

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer